Pacific Biosciences of California PACB Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's stock issuance proceeds?
- Pacific Biosciences of California (PACB) reported stock issuance proceeds of $1.44M in Q1 2026.
- How has Pacific Biosciences of California's stock issuance proceeds changed year-over-year?
- Pacific Biosciences of California's stock issuance proceeds decreased by 26.6% year-over-year, from $1.96M to $1.44M.
- What is the long-term trend for Pacific Biosciences of California's stock issuance proceeds?
- Over 3 years (2021 to 2025), Pacific Biosciences of California's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $31.81M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.